Niagen Bioscience (NAGE) announced that its board of directors has approved a share repurchase program under which the company is authorized to repurchase up to $10M of outstanding common stock over approximately 24 months.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAGE: